menu ☰
menu ˟

Institut Biochimique receives FDA clearance for OA treatment

28 Jun 2014
Institut Biochimique S.A. recently received FDA approval to market GEL-SYN, a new treatment for symptoms of osteoarthritis.An artificial material containing sodium hyaluronate — similar to hyaluronic acid found in the knee — GEL-SYN can be inject...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.